CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-14 | Ray Amrit Director | Grant or award | +7,751 | 31,116 | ||
| 2026-05-14 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +14,058 | 14,058 | ||
| 2025-05-15 | Ray Amrit Director | Grant or award | +5,740 | 23,365 | ||
| 2025-05-15 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +10,787 | 10,787 | ||
| 2024-06-18 | Ray Amrit Director | Grant or award | +5,345 | 17,625 | ||
| 2024-06-18 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +9,900 | 9,900 | ||
| 2023-06-07 | Ray Amrit Director | Grant or award | +3,860 | 12,280 | ||
| 2023-06-07 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | ||
| 2022-06-24 | Ray Amrit Director | Grant or award | +3,300 | 8,420 | ||
| 2022-06-24 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2022-04-19 | Ray Amrit Director | Grant or award | +5,120 | 5,120 | ||
| 2022-04-19 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +9,525 | 9,525 |
Page 1 of 1 · 12 trades